(ABN) ABN AMRO may now get Citigroup joining the bidding process rather than just Barclays.
(AMGN) Amgen fell another 4% to a year low after haling Vectibix trials.
(BEAV) BE Aerospace priced 10.5 million shares of common stock at $32.00, higher than the 9 million shares originally indicated.
(C’) Citigroup’s Chuck Prince being pressured by insiders to buy ABN AMRO; Citi bought 19.9% stake in Indian brokerage firm.
(CFC) Countrywide CEO told Cramer they would win in subprime area and that they were not going to be wiped out all on a CEO interview on Mad Money.
(DCX) Daimler Chrysler up another $2.00 on faster hopes for a Chrysler sale, even though the company says no news until April meeting.
(DNA) Genentech reaffirms its earnings guidance but expects first quarter revenues to be flat to Q4 2006; sees 20 new drugs in 2007-2008 but now sees more than 30 in total from 2007-2010 period.
(DNDN) Dendreon has a prostate cancer drug review at FDA next week.
(FCX) Freeport-McMoRan Copper & Gold has 41 million share common stock and 25 million convertible offering.
(GE) GE buying Sanyo unit in Japan for $1.1 Billion.
(HNAB) Hana Biosciences provides pipeline update for Marqibo Phase 2 relapsed ALL to commence.
(IMCL) Imclone trading up 14% after Amgen trial halted.
(JBL) Jabil indicated lower on forecasts under street estimates.
(KFT) Kraft is added to the S&P 500 Index to replace Sabre-TSG.
(NKE) Nike traded up slightly after beating earnings, but ended up lower on weaker margin forecasts.
(NVD) Novadel’s European formulation of Ondansetron targeted for U.S. Zensana.
(OPWV) Openwave guides earnings and revenues down; appointed new CEO effective immediately; hired Merrill Lynch to explore strategic alternatives; up 6% on hopes of buyout.
(PALM) Palm trading down less than 1% on earnings; no buyout.
(PXR) Paxar trading up 25% or more on a $30.50 buyout from Avery Dennison.
(XMSR) XM Radio was sued by members of the National Music Publishers Association because its sell receivers that allow listeners to store songs.
Jon C. Ogg
March 23, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.